Taipei Exchange - Delayed Quote TWD

Johnson Chemical Pharmaceutical Works Co., Ltd. (4747.TWO)

69.10
-0.60
(-0.86%)
At close: 1:30:16 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
595,028
611,415
606,711
494,671
411,491
Cost of Revenue
351,550
363,447
362,078
290,294
239,567
Gross Profit
243,478
247,968
244,633
204,377
171,924
Operating Expense
145,027
149,970
145,716
121,700
109,639
Operating Income
98,451
97,998
98,917
82,677
62,285
Net Non Operating Interest Income Expense
10,685
9,729
1,736
-568
-507
Pretax Income
110,087
108,708
100,889
81,534
61,939
Tax Provision
24,734
24,585
21,189
16,683
12,840
Net Income Common Stockholders
85,353
84,123
79,700
64,851
49,099
Diluted NI Available to Com Stockholders
85,353
84,123
79,700
64,851
49,099
Basic EPS
1.90
1.87
2.24
2.16
1.49
Diluted EPS
1.88
1.86
2.18
2.16
1.48
Basic Average Shares
44,919.31
44,985.56
35,580.36
33,116
33,116.05
Diluted Average Shares
45,400.40
45,227.42
36,559.63
33,184
33,207.61
Total Expenses
496,577
513,417
507,794
411,994
349,206
Net Income from Continuing & Discontinued Operation
85,353
84,123
79,700
64,851
49,099
Normalized Income
85,194.83
83,965.14
79,768.73
65,553.33
49,099
Interest Income
14,136
13,235
6,331
489
570
Interest Expense
3,451
3,506
4,595
1,057
1,077
Net Interest Income
10,685
9,729
1,736
-568
-507
EBIT
113,538
112,214
105,484
82,591
63,016
EBITDA
134,175
133,186
126,591
100,857
78,303
Reconciled Cost of Revenue
351,550
363,447
362,078
290,294
239,567
Reconciled Depreciation
20,637
20,972
21,107
18,266
15,287
Net Income from Continuing Operation Net Minority Interest
85,353
84,123
79,700
64,851
49,099
Total Unusual Items Excluding Goodwill
204
204
-87
-883
0
Total Unusual Items
204
204
-87
-883
0
Normalized EBITDA
133,971
132,982
126,678
101,740
78,303
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
45.83
46.14
-18.27
-180.67
0
12/31/2021 - 6/28/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6496.TWO Excelsior Biopharma Inc.
25.80
-0.58%
 
4120.TWO Orient EuroPharma Co., Ltd.
47.50
-1.76%
 
4127.TWO Tien Liang BioTech Co., Ltd.
39.00
+0.26%
 
8432.TWO TSH Biopharm Corporation Limited
51.70
+2.38%
 
1796.TWO GeneFerm Biotechnology Co., Ltd.
47.70
+0.32%
 
6576.TWO Foresee Pharmaceuticals Co., Ltd.
64.40
+0.31%
 
1720.TW Standard Chemical & Pharmaceutical Co. Ltd.
58.60
+0.34%
 
4119.TW SCI Pharmtech, Inc.
70.80
+1.72%
 
4114.TWO Synmosa Biopharma Corporation
32.90
-0.15%
 
1799.TWO Easywell Biomedicals, Inc.
61.60
0.00%